Eric Aguiar

Eric Aguiar

Direktor/Vorstandsmitglied bei BIOMEA FUSION, INC.

Vermögen: 125 $ am 31.05.2024

62 Jahre
Health Technology
Finance
Consumer Services

Profil

Eric I.
Aguiar
is currently the Lead Independent Director at Invitae Corp., the Director at BridgeBio Pharma LLC, the Independent Director at BridgeBio Pharma, Inc., the Lead Independent Director at Biomea Fusion, Inc., the Director at Garuda Therapeutics, Inc., a Partner at Aisling Capital LLC, a Member of the Council on Foreign Relations, Inc., and a Council Member at Tufts University School of Medicine.
He previously worked as the Chief Executive Officer & Director at Genovo, Inc., the Executive Director at TheraTech, Inc., the Non-Executive Director at Amarin Corp.
Plc, a Director at 3-Dimensional Pharmaceuticals, Inc., an Independent Director at Oriel Therapeutics, Inc., a Director at CardioKine, Inc., a Director at SkinMedica, Inc., a Director at Virdante Pharmaceuticals, Inc., a Managing Director at HealthCare Ventures LLC, a Director at Amarin Pharmaceuticals, Inc., a Director at Metaphore Pharmaceuticals, Inc., a Director at VaxInnate Corp., a Director at Intuity Medical, Inc., a Director at Locus Development, Inc., an Independent Director at Biohaven Pharmaceutical Holding Co. Ltd., and the Vice President & Managing Director at Philadelphia Ventures, Inc. He also served as an Independent Director at Eidos Therapeutics, Inc., a Director at Biohaven Ltd., and a Partner at Thomas, McNerney & Partners LLC.
Dr. Aguiar received his undergraduate degree from Cornell University and his doctorate from Harvard Medical School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
27.04.2023 125 322 ( 0,04% ) 125 $ 31.05.2024
12.06.2024 0 ( -.--% ) - $ 31.05.2024
01.04.2024 0 ( -.--% ) - $ 31.05.2024

Aktive Positionen von Eric Aguiar

UnternehmenPositionBeginn
INVITAE CORPORATION Direktor/Vorstandsmitglied -
BRIDGEBIO PHARMA, INC. Direktor/Vorstandsmitglied 01.03.2019
BIOMEA FUSION, INC. Direktor/Vorstandsmitglied 01.12.2020
Tufts University School of Medicine Corporate Officer/Principal -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.03.2019
Private Equity Investor 01.01.2016
Corporate Officer/Principal -
Alle aktiven Positionen von Eric Aguiar

Ehemalige bekannte Positionen von Eric Aguiar

UnternehmenPositionEnde
EIDOS THERAPEUTICS, INC. Direktor/Vorstandsmitglied -
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Eric Aguiar im Detail an

Ausbildung von Eric Aguiar

Cornell University Undergraduate Degree
Harvard Medical School Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Eric Aguiar im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

29

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
AMARIN CORPORATION PLC

Health Technology

INVITAE CORPORATION

Health Services

BRIDGEBIO PHARMA, INC.

Health Technology

BIOMEA FUSION, INC.

Health Technology

BIOHAVEN LTD.

Health Technology

Private Unternehmen21

Finance

Health Technology

Health Technology

Finance

Health Technology

Distribution Services

Distribution Services

Finance

Health Technology

Distribution Services

Health Technology

Miscellaneous

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Eric Aguiar